Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating RM-131 in Parkinson's disease (with chronic constipation) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Parkinson Disease

Drugs mentioned

• RM-131

Snippet

Sponsor: Motus Therapeutics, Inc. | Conditions: Parkinson's Disease | Phase 2 | Status: TERMINATED